Patents by Inventor Xingfu XU

Xingfu XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952575
    Abstract: A transaminase mutant and use hereof, the amino acid sequence of the transaminase mutant is an amino acid sequence in which the amino acid sequence as represented by SEQ ID NO: 1 is mutated, the mutated amino acid position being one or more selected from among F89, K193, P243, V234, I262, Q280, V379, R416, A417 and C418. The enzymatic activity and/or stability of the transaminase mutant is improved.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: April 9, 2024
    Assignee: ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD
    Inventors: Hao Hong, Gage James, Jiangping Lu, Xingfu Xu, Wenyan Yu, Xin Huang, Yulei Ma, Yibing Cheng
  • Patent number: 11359219
    Abstract: The invention provides a transaminase mutant and application thereof, wherein the amino acid sequence of the transaminase mutant is formed after mutation of the amino acid sequence as shown in SEQ ID NO: 1, and mutated amino acid sites comprise T7C+S47C sites. The transaminase mutant having the mutation sites can be further prepared into an immobilized enzyme through an immobilization technology, the immobilized enzyme has relatively high activity and high stability, can be recycled for multiple times, and is applicable to continuous flow reaction in a packed bed.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: June 14, 2022
    Assignee: ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD
    Inventors: Hao Hong, Gage James, Jiangping Lu, Xingfu Xu, Yuxia Cui, Na Zhang, Xuewu Dong, Wenyan Yu, Xin Huang, Mingmin Hao, Yulei Ma, Yibing Cheng, Jiadong Zhao
  • Patent number: 11162081
    Abstract: A ketoreductase mutant and use thereof are provided. The amino acid sequence of the ketoreductase mutant is an amino acid sequence obtained by mutation of the amino acid sequence shown in SEQ ID NO: 1, wherein the mutation at least comprises one of the following mutation sites: position 6, position 94, position 96, position 117, position 144, position 156, position 193, position 205, position 224, position 176, position 85 and position 108; alternatively, the amino acid sequence of the ketoreductase mutant has a mutation site in a mutated amino acid sequence and an amino acid sequence having 80% or more homology with the mutated amino acid sequence.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: November 2, 2021
    Assignee: JILIN ASYMCHEM LABORATORIES CO., LTD.
    Inventors: Hao Hong, Gage James, Jiangping Lu, Xingfu Xu, Wenyan Yu, Na Zhang, Yulei Ma, Yibing Cheng, Huiyan Mu
  • Publication number: 20210054428
    Abstract: The invention provides a transaminase mutant and application thereof, wherein the amino acid sequence of the transaminase mutant is formed after mutation of the amino acid sequence as shown in SEQ ID NO: 1, and mutated amino acid sites comprise T7C+S47C sites. The transaminase mutant having the mutation sites can be further prepared into an immobilized enzyme through an immobilization technology, the immobilized enzyme has relatively high activity and high stability, can be recycled for multiple times, and is applicable to continuous flow reaction in a packed bed.
    Type: Application
    Filed: February 5, 2018
    Publication date: February 25, 2021
    Inventors: Hao HONG, Gage JAMES, Jiangping LU, Xingfu XU, Yuxia CUI, Na ZHANG, Xuewu DONG, Wenyan YU, Xin HUANG, Mingmin HAO, Yulei MA, Yibing CHENG, Jiadong ZHAO
  • Publication number: 20200354694
    Abstract: A ketoreductase mutant and use thereof are provided. The amino acid sequence of the ketoreductase mutant is an amino acid sequence obtained by mutation of the amino acid sequence shown in SEQ ID NO: 1, wherein the mutation at least comprises one of the following mutation sites: position 6, position 94, position 96, position 117, position 144, position 156, position 193, position 205, position 224, position 176, position 85 and position 108; alternatively, the amino acid sequence of the ketoreductase mutant has a mutation site in a mutated amino acid sequence and an amino acid sequence having 80% or more homology with the mutated amino acid sequence.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 12, 2020
    Inventors: Hao HONG, Gage JAMES, Jiangping LU, Xingfu XU, Wenyan YU, Na ZHANG, Yulei MA, Yibing CHENG, Huiyan MU
  • Publication number: 20200239895
    Abstract: A transaminase mutant and use hereof, the amino acid sequence of the transaminase mutant is an amino acid sequence in which the amino acid sequence as represented by SEQ ID NO: 1 is mutated, the mutated amino acid position being one or more selected from among F89, K193, P243, V234, I262, Q280, V379, R416, A417 and C418. The enzymatic activity and/or stability of the transaminase mutant is improved.
    Type: Application
    Filed: November 15, 2017
    Publication date: July 30, 2020
    Applicant: Asymchem Life Science (Tianjin) Co., Ltd
    Inventors: Hao HONG, Gage JAMES, Jiangping LU, Xingfu XU, Wenyan YU, Xin HUANG, Yulei MA, Yibing CHENG
  • Patent number: D916595
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: April 20, 2021
    Assignee: GUANGZHOU YIDINGCHENG BIOLOGICAL TECHNOLOGY CO., LTD
    Inventor: Xingfu Xu